M. Olivares

Newbiotechnic (Spain)

Research Areas

• Probiotics and Fermented Foods
• Gut microbiota and health
• Infant Nutrition and Health
• Infant Health and Development
• Fatty Acid Research and Health

Health Outcomes Studied

• Enhanced Natural Killer Cell Tumoricidal Activity
• Improved Bowel Movement Frequency
• Improved Gut Microbiota
• Improved Gut Microbiota Composition
• Increased Fecal Butyrate Levels
• Increased Fecal Lactobacilli
• Increased IL-12 Levels
• Increased Interleukin-10 Levels
• Increased Plasma Immunoglobulin Levels
• Increased Stool Volume
• Reduced Interleukin-6 Levels
• Reduced Tumor Necrosis Factor Alpha

Papers (27)

• 2021
  Evaluation of the Effect of Limosilactobacillus fermentum CECT5716 on Gastrointestinal Infections in Infants: A Systematic Review and Meta-Analysis.10.3390/microorganisms9071412
• 2021
  Efficacy of Bifidobacterium breve CECT7263 for infantile colic treatment: an open-label, parallel, randomised, controlled trial.10.3920/bm2020.0105
• 2021
  Efficacy of Bifidobacterium breve CECT7263 for infantile colic treatment: an open-label, parallel, randomised, controlled trial.10.3920/BM2020.0105
• 2020
  Effects of Lactobacillus fermentum CECT5716 Lc40 on infant growth and health: a randomised clinical trial in nursing women.10.3920/bm2019.0180
• 2020
  Effects of Lactobacillus fermentum CECT5716 Lc40 on infant growth and health: a randomised clinical trial in nursing women.10.3920/BM2019.0180
• 2019
  Lactobacillus reuteri V3401 Reduces Inflammatory Biomarkers and Modifies the Gastrointestinal Microbiome in Adults with Metabolic Syndrome: The PROSIR Study10.3390/nu11081761
• 2019
  Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial10.1186/s12887-019-1753-7
• 2018
  Lactobacillus fermentum Improves Tacrolimus‐Induced Hypertension by Restoring Vascular Redox State and Improving eNOS Coupling10.1002/mnfr.201800033
• 2018
  The Probiotic Lactobacillus fermentum Prevents Dysbiosis and Vascular Oxidative Stress in Rats with Hypertension Induced by Chronic Nitric Oxide Blockade10.1002/mnfr.201800298
• 2017
  A synbiotic composed of Lactobacillus fermentum CECT5716 and FOS prevents the development of fatty acid liver and glycemic alterations in rats fed a high fructose diet associated with changes in the microbiota.10.1002/mnfr.201600622
• 2017
  Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition.10.1002/mnfr.201700144
• 2016
  The viability of Lactobacillus fermentum CECT5716 is not essential to exert intestinal anti-inflammatory properties.10.1039/c4fo00938j
• 2015
  Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats.10.1002/mnfr.201500290
• 2014Primary author
  Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease10.1017/S0007114514000609
• 2012
  Human Milk Probiotic Lactobacillus fermentum CECT5716 Reduces the Incidence of Gastrointestinal and Upper Respiratory Tract Infections in Infants10.1097/MPG.0b013e3182333f18
• 2012
  Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial.10.1016/j.phrs.2011.11.016
• 2011
  The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine10.1007/s00394-011-0221-4
• 2010
  Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults.10.1016/j.anaerobe.2010.02.001
• 2010
  Safety and tolerance of the human milk probiotic strain Lactobacillus salivarius CECT5713 in 6-month-old children.10.1016/j.nut.2009.08.023
• 2009
  Safety Assessment of Lactobacillus fermentum CECT5716, a probiotic strain isolated from human milk10.1017/S0022029909004014
• 2008
  Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice10.1017/S0007114508986876
• 2008
  Oral Administration of Lactobacillus Strains Isolated from Breast Milk as an Alternative for the Treatment of Infectious Mastitis during Lactation10.1128/AEM.02599-07
• 2007Primary author
  Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination.10.1016/J.NUT.2007.01.004
• 2007
  Safety assessment of the human milk-isolated probiotic Lactobacillus salivarius CECT5713.10.3168/JDS.2006-685
• 2006Primary author
  Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults.10.1016/J.IJFOODMICRO.2005.08.019
• 2006Primary author
  Antimicrobial potential of four Lactobacillus strains isolated from breast milk10.1111/j.1365-2672.2006.02981.x
• 2006
  Lactobacillus salivarius CECT 5713, a potential probiotic strain isolated from infant feces and breast milk of a mother-child pair.10.1016/J.IJFOODMICRO.2006.06.011